Lai CL - Search Results

1

Precore sequence variation in Chinese isolates of hepatitis B virus.

Carman WF, Ferrao M, Lok AS, Ma OC, Lai CL, Thomas HC. Carman WF, et al. Among authors: lai cl. J Infect Dis. 1992 Jan;165(1):127-33. doi: 10.1093/infdis/165.1.127. J Infect Dis. 1992. PMID: 1727881

2

A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection.

Lau JY, Lai CL, Wu PC, Chung HT, Lok AS, Lin HJ. Lau JY, et al. Among authors: lai cl. J Med Virol. 1991 Jul;34(3):184-7. doi: 10.1002/jmv.1890340310. J Med Virol. 1991. PMID: 1919540 Clinical Trial.

3

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology.

Lok AS, Lai CL. Lok AS, et al. Among authors: lai cl. J Hepatol. 1990 Jan;10(1):29-34. doi: 10.1016/0168-8278(90)90069-4. J Hepatol. 1990. PMID: 2307827

4

Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.

Chung HT, Lai CL, Lok AS. Chung HT, et al. Among authors: lai cl. Hepatology. 1995 Jul;22(1):25-9. Hepatology. 1995. PMID: 7601418

5

Re-evaluation of alpha-interferon treatment of chronic hepatitis B using polymerase chain reaction.

Chung HT, Lok AS, Lai CL. Chung HT, et al. Among authors: lai cl. J Hepatol. 1993 Feb;17(2):208-14. doi: 10.1016/s0168-8278(05)80040-6. J Hepatol. 1993. PMID: 8445234 Clinical Trial.

6

Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong Kong.

Lok AS, Wong A, Sporton S, Lai CL, Liu V, Chung HT. Lok AS, et al. Among authors: lai cl. J Hepatol. 1992 Mar;14(2-3):332-4. doi: 10.1016/0168-8278(92)90179-s. J Hepatol. 1992. PMID: 1500697

7

Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera.

Lok AS, Ma OC, Chan TM, Lai CL, Chung HT, Ng CP, Lam JS. Lok AS, et al. Among authors: lai cl. Hepatology. 1991 Nov;14(5):756-62. doi: 10.1002/hep.1840140503. Hepatology. 1991. PMID: 1657751

8

Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases.

Lok AS, Lai CL, Chung HT, Lau JY, Leung EK, Wong LS. Lok AS, et al. Among authors: lai cl. Hepatology. 1991 May;13(5):834-7. doi: 10.1002/hep.1840130506. Hepatology. 1991. PMID: 1709410

9

Alpha-interferon treatment in Chinese patients with chronic hepatitis B.

Lok AS, Lai CL, Wu PC, Lau JY, Leung EK, Wong LS, Fung YL. Lok AS, et al. Among authors: lai cl. J Hepatol. 1990;11 Suppl 1:S121-5. doi: 10.1016/0168-8278(90)90177-s. J Hepatol. 1990. PMID: 2079568 Clinical Trial.

10

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection.

Lok AS, Lai CL, Leung EK. Lok AS, et al. Among authors: lai cl. Hepatology. 1990 Dec;12(6):1266-70. doi: 10.1002/hep.1840120603. Hepatology. 1990. PMID: 2258142 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

890 results

Search Page

Filters